Despite increasing numbers of cancer drugs being licensed, an analysis has found that highly innovative drugs took longer to reach NHS patients than more conventional treatments.

Professor Paul Workman has announced his intention to step down as Chief Executive of The Institute of Cancer Research, London, in around a year's time after more than six years in the role.

A new report urges biomedical researchers to use online web resources very carefully, taking into account their complementary benefits and weaknesses, when selecting small-molecule chemical probes to help answer their research questions.